What does aducanumab treatment of Alzheimer's disease mean for research on vascular cognitive disorders?

• Controversial registration of aducanumab for Alzheimer's Disease; • Aducanumab is the subject of post-licensing observational studies aiming to follow the effects of the drug; • Given the high prevalence of cerebrovascular pathology it is important that these studies do not ignore vascular co...

Descripción completa

Detalles Bibliográficos
Autores principales: Wallin, Anders, Alladi, Suvarna, Black, Sandra E, Chen, Christopher, Greenberg, Steven M, Gustafson, Deborah, Isaacs, Jeremy D, Jokinen, Hanna, Kalaria, Raj, Mok, Vincent, Pantoni, Leonardo, Pasquier, Florence, Roman, Gustavo C, Rosenberg, Gary A., Schmidt, Reinhold, Smith, Eric E, Hainsworth, Atticus H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9616233/
https://www.ncbi.nlm.nih.gov/pubmed/36324416
http://dx.doi.org/10.1016/j.cccb.2022.100044

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9616233/
https://www.ncbi.nlm.nih.gov/pubmed/36324416
http://dx.doi.org/10.1016/j.cccb.2022.100044

Ejemplares similares